Clinical Trial: A Double-Blind, Comparative, Randomized Clinical Study to Evaluate the Pharmacokinetics, Safety, and Immunogenicity of BCD-057 100 mg/mL, BCD-057 50 mg/mL, and Humira 100 mg/mL After a Single Subcutaneous Injection in Healthy Subjects

U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07181694) titled 'A Double-Blind, Comparative, Randomized Clinical Study to Evaluate the Pharmacokinetics, Safety, and Immunogenicity of BCD-057 100 mg/mL, BCD-057 50 mg/mL, and Humira 100 mg/mL After a Single Subcutaneous Injection in Healthy Subjects' on Sept. 12.

Brief Summary: The aim of this study is to establish comparability of pharmacokinetic parameters and similarity of the safety and immunogenicity profiles of single subcutaneous doses of BCD 057 100 mg/mL and BCD-057 50 mg/mL, as well as BCD-057 100 mg/mL and Humira 100 mg/mL, in healthy subjects. The study is conducted in a population of healthy male subjects aged 18-45 years inclusive a...